News

Gilead to acquire Forty Seven for $4.9 billion

Through the addition of Forty Seven’s investigational lead product candidate, magrolimab, the acquisition will strengthen Gilead’s immuno-oncology research and development portfolio

Mar 03, 2020

By : Team ABLE

ICGEB researchers develop method to boost biofuel production from marine microorganism

The researchers have successfully engineered a marine cyanobacterium called Synechococcus sp. PCC 7002 which showed a higher growth rate and sugar (glycogen) content.

Feb 28, 2020

By : Team ABLE

Faridabad-based Regional Centre for Biotechnology professor bags Rs. 3.6 crore grant to promote research on pigmentary disorder

Wellcome Trust/DBT India Alliance has conferred an Intermediate Fellowship Award on Dr. Rajender K. Motianito understand the problem of pigmentary disorders.

Feb 28, 2020

By : Team ABLE

ILS researchers discover ultra-sensitive qPCR assay for asymptomatic malaria diagnosis

Dr. V. Arun Nagaraj of Institute of Life Sciences and Srinivasa Raju of Jigsaw Bio Solutions Pvt. Ltd used a new concept of genome mining to develop an ultra-sensitive qPCR assay for malaria diagnosis.

Feb 28, 2020

By : Team ABLE

Vimta Labs establishes Centre of Excellence for Bioassays at Hyderabad

Contract Research and Testing Organization, Vimta Labs recently conducted Confluence - 2020, a knowledge sharing session to sensitize pharma industry about upcoming regulatory and scientific developments.The theme of the event was on development of large molecule drugs also called as biologics. Scientists and researchers from various parts of the globe interacted with the participants about the developments in their respective areas of research at this event.

Feb 28, 2020

By : Team ABLE